Karyopharm Therapeutics Inc
Statements
Cash Flow
Karyopharm Therapeutics Inc (KPTI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -25 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -30 | -19 | -44 | -38 | -19 | -26 | -39 | -19 | -5.9 | -12 | -23 | -25 | -65 | |
| 0.3 | 0.3 | 0.3 | 0.1 | 2.5 | 2.4 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 5.1 | 5.2 | 5.0 | 5.4 | 4.2 | 3.9 | 3.6 | 3.8 | 2.8 | 3.9 | 3.0 | 1.9 | 12 | |
| 1.9 | 17 | -13 | -9.5 | 7.5 | 10 | -1.5 | 10 | 14 | 5.5 | 3.9 | 1.3 | 25 | |
| 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -7.7 | 27 | 22 | 51 | 7.5 | 15 | 15 | 18 | 4.8 | 5.0 | 3.2 | -10 | 3.0 | |
| – | – | – | – | 111 | – | – | – | – | – | – | – | – | |
| – | – | – | – | 0.0 | 41 | – | – | 0.0 | 27 | – | – | – | |
| 39 | 0.3 | – | 41 | 0.0 | 0.7 | 0.0 | 0.4 | 0.0 | 30 | 50 | -0.9 | 79 | |
| -37 | 8.6 | -22 | 54 | -12 | -10 | -24 | 0.0 | -1.1 | 23 | 30 | -36 | 16 | |
| -30 | -19 | -44 | -38 | -19 | -26 | -39 | -19 | -5.9 | -12 | -23 | -25 | -65 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.